Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about AWKNF

Recent news which mentions AWKNF

< Previous 1 2 3 Next >
Awakn Partners With University Of Nottingham For Preclinical Testing Of Psychoactive Therapy
Tickers AWKNF NEWS
Tags Market News Cannabis Madeleine King
From Benzinga
Investors Back Awakn's Psychedelic Therapies, As Company Doubles Private Placement To $2M
Tickers AWKNF NEWS
Tags Awakn Market News Cannabis
From Benzinga
Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More
Tickers AWKNF BETRF CMND FLHLF
Tags AWKNF Benzinga Psychedelics
From Benzinga
Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More
Tickers ATAI AWKNF CMND CYBN
Tags Legal Psychedelic/Assisted Therapies IXHL
From Benzinga
Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, 'Synthetic Surprise,' UK's Harm Reduction Hub And More
Tickers AWKNF CMND CMPS FLHLF
Tags Management MDXXF Financing
From Benzinga
Psyched: Biden Approves Psychedelics Trials, RFK, Australia's First Legal Dedicated Clinic & More
Tickers ATAI AWKNF CMND CMPS
Tags Cannabis SILO GHRS
From Benzinga
Awakn Life Sciences Enters Into Global Licensing Agreement For Sublingual Delivery Formulation
Tickers AWKNF
Tags Ketamine Psychedelics Benzinga
From Benzinga
Psyched: Ramaswamy Psychedelics For PTSD, UK Clinical Trials, Johns Hopkins Q&A And More
Tickers ATAI AWKNF CMPS CYBN
Tags Psychedelics CYBN Vivek Ramaswamy
From Benzinga
UK Psychedelics: Phase 3 Depression & Alcohol Addiction Trials, New London Center
Tickers AWKNF CMPS
Tags Cannabis Market News severe alcohol use disorder
From Benzinga
U.K.'s Prof. David Nutt Ranked World's Top Psychopharmacologist: More On His Contributions & Advocacy
Tickers AWKNF
Tags Imperial College London Psychedelic Science 2023 Conference AWKNF
From Benzinga
Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More
Tickers ATAI AWKNF CMND CMPS
Tags ENVB PSIL OPTHF
From Benzinga
Awakn Life Sciences Submits CTA For Phase III Alcohol Use Disorder Clinical Trial
Tickers AWKNF
Tags General Ketamine AWKNF
From Benzinga
Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More
Tickers AGNPF ATAI AWKNF CMPS
Tags News ATAI Penny Stocks
From Benzinga
Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More
Tickers ATAI AWKNF CMPS CYBN
Tags MNMD Psilocybin program AWKNF
From Benzinga
Awakn Life Sciences Becomes Pure R&D Biotech After Sale Of Norway Clinics
Tickers AWKNF
Tags Psychedelic/Assisted Therapies Benzinga Psychedelics
From Benzinga
Awakn Life Sciences On Track With Phase 3 Trial To Research Substance Use Disorder
Tickers AWKNF
Tags Substance Use Disorder Ketamine Penny Stocks
From Benzinga
Psyched: Australia's Innovative Program, Congressional Amendments, Therapy Reimbursement And More
Tickers AWKNF CMPS DMTTF FLHLF
Tags Small Cap Psychedelics Reform Psychedelics Financing
From Benzinga
Awakn Life Sciences Sells London Clinics Business, Hopes To Divest Norwegian Unit Next
Tickers AWKNF
Tags Benzinga Psychedelics AWKNF
From Benzinga
Awakn Life Sciences Announces Closing Of Second Tranche And Upsizing Of Previous Private Placement
Tickers AWKNF
Tags Financing Psychedelic/Assisted Therapies Psychedelics
From Benzinga
Awakn To Focus On R&D Of Addiction Therapies, Moves Away From Ketamine Treatment For Alcoholism
Tickers AWKNF
Tags AWKNF Benzinga Psychedelics
From Benzinga
Psyched: Oregon And Colorado Regulations, MindMed CEO Discusses LSD Therapy, Mia Khalifa Enters Market & More
Tickers AWKNF IXHL MNMD MSSTF
Tags TRYPF Penny Stocks TRUFF
From Benzinga
Awakn's Q4 2023 And Annual Financials, +500% YoY Revenue Increase Following Network Expansion
Tickers AWKNF
Tags News financials alcohol use disorder
From Benzinga
Psyched: LSD For Major Depression, Canada's Psilocybin Macrodose Trial, Treatments For Multiple Sclerosis And More
Tickers AWKNF CMND DRUG HUGE
Tags NMLSF Psychedelic/Assisted Therapies LOBEF
From Benzinga
Severe Alcohol Use Disorder Patients Will Try Ketamine Therapy At Awakn's New Phase 3 Study
Tickers AWKNF
Tags Global University of Exeter Contracts
From Benzinga
EXCLUSIVE: MDMA Therapy Experts Debate Upcoming Approval And Psychedelic Market Opps
Tickers AWKNF
Tags Robert Velarde News Exclusives
From Benzinga
Psyched: Clinical-Grade MDMA, LSD For Depression, Partnerships For Delivering Psychedelic Therapies & More
Tickers ATAI AWKNF CYBN FLHLF
Tags Contracts PSIL Market News
From Benzinga
Awakn's Psychedelics Medical Chief Steps Down, Shifts In Company's Stocks And Ownership
Tickers AWKNF
Tags Benzinga Psychedelics Penny Stocks
From Benzinga
EXCLUSIVE: Ketamine Therapy Provider Nushama Co-Founder On Shifting From A Consciousness Of Blame Into A Space Of Responsibility
Tickers AWKNF
Tags Management Ketamine/Assisted Therapy Jay Godfrey
From Benzinga
Major Psychedelics VC & EFT Directors Will Share Valuable Insights At Upcoming Benzinga Event
Tickers ATAI AWKNF CYBN DMTTF
Tags MNMD AWKNF Simeon Schnapper
From Benzinga
Psyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & More
Tickers AGNPF AWKNF BRAXF CMPS
Tags Markets Market News OPTHF
From Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.